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Supplementary Figure S3
Measurement of magnetic field strength
To isolate EpCAM positive cells in the blood sample, an NbFeB permanent magnet (50 mm X 50 mm X 25mm) was placed under the cell isolating segment (schemed as Figure a) with N pole upwards and S pole downwards. We measured the magnetic field strength of 5 points, using a digital gaussmeter (HT20, Hengtong, China). To adapt the situation that cell are labelled with different amount of magnetic beads, a gradually-widened micro fluidic channel was designed to avoid channel jamming and better cell isolation efficiency by gradually weakening the flow velocity and related drag force. Ideally, cells with more magnetic beads would be captured in the front of the channel, while cells with fewer magnetic beads would be captured in the rear of the channel.
We quantitatively analysed the distribution of isolated cells in a gradually-widened channel and a straight rectangle channel. The depth of both channel is 20 µm, other dimensions are showed in We further verified this design with 2 mL clinical blood sample. After incubation with 10 µL immuno-magnetic beads conjugated with EpCAM antibody for 30 minutes, we diluted the blood to 5 mL and pumped them into the microfluidic chip. Before flowing into the gradually-widened isolating channel for cell isolating, the blood was filtering by the micro-pillar array. Then we immuno-stained all cells with DAPI, CK19-FITC and CD45-PE. (a) We compared the automatic CTC enumeration and traditional tube-based CTC isolation combined with manually identification. We took 4 mL blood from a patient, and then divided it into 2 equal parts. 2 mL was treated by automatic CTC enumeration while the other 2 mL was manually examined using tube-based isolation. All identified CTCs from both assays were listed. 6
CTCs were found by automatic CTC enumeration while only 3 were found by manually 
